Compare ELMD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELMD | TKNO |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.9M | 268.1M |
| IPO Year | 2010 | 2021 |
| Metric | ELMD | TKNO |
|---|---|---|
| Price | $41.58 | $5.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 112.7K | ★ 115.2K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | 43.86 |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $54,716,000.00 | $40,520,000.00 |
| Revenue This Year | $15.59 | $8.27 |
| Revenue Next Year | $11.51 | $13.13 |
| P/E Ratio | $44.76 | ★ N/A |
| Revenue Growth | ★ 13.83 | 7.35 |
| 52 Week Low | $18.14 | $1.91 |
| 52 Week High | $47.40 | $6.68 |
| Indicator | ELMD | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 54.52 | 51.19 |
| Support Level | $23.46 | $5.00 |
| Resistance Level | $47.40 | $5.88 |
| Average True Range (ATR) | 1.81 | 0.36 |
| MACD | -0.25 | -0.05 |
| Stochastic Oscillator | 57.78 | 45.36 |
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.